相关实验视频
Updated: Aug 15, 2026

10:23
Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
10.2K
在COVID-19感染中绘制脂质特征:诊断和治疗解决方案
Aishi Dasgupta1,2, Shon Gangai3, Rishikesh Narayan3,4
1Department of Chemistry, Indian Institute of Technology Bombay, Mumbai 400076, India.
Journal of medicinal chemistry
|October 30, 2023
概括
这篇评论强调了SARS-CoV-2如何劫持宿主细胞脂质以进行病毒复制和致病. 准这些脂质过程为开发新的COVID-19疗法和生物标志物提供了一个有前途的战略.
科学领域:
- 生物化学 生物化学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 由于COVID-19的流行,需要新的治疗点和生物标志物.
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 利用宿主细胞代谢,特别是脂质,为其生命周期.
- 了解感染期间宿主脂质重塑对于治疗的发展至关重要.
研究的目的:
- 审查脂质在SARS-CoV-2病变发生过程中的多方面的作用.
- 为抗病毒策略确定以脂质为中心的点.
- 讨论脂质组变化的潜力,作为COVID-19的诊断和预后生物标志物.
主要方法:
- 对SARS-CoV-2和宿主脂质代谢研究的文献综述.
- 对感染患者的脂质学数据的分析.
- 综合关于基于脂质的治疗方法的信息.
主要成果:
- SARS-CoV-2利用宿主脂质进行病毒的进入,贩运,免疫逃避,复制和释放.
- 在SARS-CoV-2感染时发生了显著的宿主细胞脂质代谢重编程.
- 患者的变化的脂质样本可以作为有价值的临床生物标志物.
结论:
- 准宿主脂质代谢是对抗SARS-CoV-2的可行策略.
- 脂质启发的疗法为蛋白质向治疗提供了一种补充方法,有可能克服病毒突变.
- 对宿主脂质通路的进一步研究可以为当前和未来的病毒大流行提供有效的干预措施.
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

